Orrell Equine Veterinary Practice Limited 30/03/2025 iXBRL

Company registration number: 06547469

Orrell Equine Veterinary Practice Limited

Unaudited filleted financial statements

30 March 2025

Orrell Equine Veterinary Practice Limited

Contents

Directors and other information

Directors report

Accountants report

Statement of financial position

Notes to the financial statements

Orrell Equine Veterinary Practice Limited

Directors and other information


	Directors	Mr Stevan John Orrell


	Secretary	Stevan John Orrell


	Company number	06547469


	Registered office	2 Wigan Road
		Golborne
		Warrington
		WA3 3UA


	Business address	2 Wigan Road
		Golborne
		Warrington
		WA3 3UA


	Accountants	Practical Business Solutions (NW) Limited
		749a
		Ormskirk Road
		Wigan
		WN5 8AT

Orrell Equine Veterinary Practice Limited

Directors report

Year ended 30 March 2025

The directors present their report and the unaudited financial statements of the company for the year ended 30 March 2025.

Directors

The directors who served the company during the year were as follows:

Mr Stevan John Orrell

Particulars of recommended dividends are detailed in note 6 to the unaudited financial statements.

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 22 December 2025 and signed on behalf of the board by:

Mr Stevan John Orrell

Director

Orrell Equine Veterinary Practice Limited

Report to the board of directors on the preparation of the

unaudited statutory financial statements of Orrell Equine Veterinary Practice Limited

Year ended 30 March 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Orrell Equine Veterinary Practice Limited for the year ended 30 March 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Chartered Institute of Management Accountants , we are subject to its ethical and other professional requirements which are detailed at www.cimaglobal.com.

This report is made solely to the board of directors of Orrell Equine Veterinary Practice Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Orrell Equine Veterinary Practice Limited and state those matters that we have agreed to state to the board of directors of Orrell Equine Veterinary Practice Limited as a body, in this report in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at www.cimaglobal.com. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Orrell Equine Veterinary Practice Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Orrell Equine Veterinary Practice Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Orrell Equine Veterinary Practice Limited. You consider that Orrell Equine Veterinary Practice Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Orrell Equine Veterinary Practice Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Practical Business Solutions (NW) Limited

Chartered Global Management Accountant

749a

Ormskirk Road

Wigan

WN5 8AT

22 December 2025

Orrell Equine Veterinary Practice Limited

Statement of financial position

30 March 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Intangible assets	7	-		-
Tangible assets	8	402,896		396,789
		_______		_______
			402,896		396,789

Current assets
Stocks		24,318		16,033
Debtors	9	23,988		54,755
Cash at bank and in hand		68,767		209,021
		_______		_______
		117,073		279,809
Creditors: amounts falling due
within one year	10	( 113,239)		( 163,886)
		_______		_______
Net current assets			3,834		115,923
			_______		_______
Total assets less current liabilities			406,730		512,712

Creditors: amounts falling due
after more than one year	11		( 3,911)		-

Provisions for liabilities			( 19,549)		( 11,919)

			_______		_______
Net assets			383,270		500,793
			_______		_______

Capital and reserves
Called up share capital			1		1
Revaluation reserve			62,734		62,734
Profit and loss account			320,535		438,058
			_______		_______
Shareholders funds			383,270		500,793
			_______		_______

For the year ending 30 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 22 December 2025 , and are signed on behalf of the board by:

Mr Stevan John Orrell

Director

Company registration number: 06547469

Orrell Equine Veterinary Practice Limited

Notes to the financial statements

Year ended 30 March 2025

1. General information

The company is a private company limited by shares, registered in England. The address of the registered office is Orrell Equine Veterinary Practice Limited, 2 Wigan Road, Golborne, Warrington, WA3 3UA.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:


Plant and machinery	-	25 %	reducing balance
Fittings fixtures and equipment	-	25 %	reducing balance
Motor vehicles	-	25 %	reducing balance

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Investment property

Investment property is measured initially at cost, which includes purchase price and any directly attributable expenditure. Investment property is revalued to its fair value at each reporting date and any changes in fair value are recognised in profit or loss.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

Share-based payments

Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value is expensed on a straight-line basis over the vesting period, with a corresponding increase in equity. This is based upon the company's estimate of the shares or share options that will eventually vest which takes into account all vesting conditions and non-market performance conditions, with adjustments being made where new information indicates the number of shares or share options expected to vest differs from previous estimates. Fair value is determined using an appropriate pricing model. All market conditions and non-vesting conditions are taken into account when estimating the fair value of the shares or share options. As long as all other vesting conditions are satsfied, no adjustment is made irrespective of whether market or non-vesting conditions are met. Where the terms of an equity-settled transaction are modified, an expense is recognised as if the terms had not been modified. In addition, an expense is recognised for any increase in the fair value of the transaction, as measured at the date of modification. Where an equity-settled transaction is cancelled or settled, it is treated as if it had vested on the date of cancellation or settlement, and any expense not yet recognised in profit or loss is expensed immediately. Cash-settled share-based payment transactions are measured at the fair value of the liability. Until the liability is settled, the fair value of the liability is re-measured at each reporting date and at the date of settlement, with any changes in fair value recognised in profit or loss for the period.

4. Staff costs

The average number of persons employed by the company during the year amounted to 6 (2024: 7 ).

The aggregate payroll costs incurred during the year were:

	2025	2024
	£	£
Wages and salaries	293,001	232,619
Social security costs	25,915	19,761
Other pension costs	144,390	4,022
	_______	_______
	463,306	256,402
	_______	_______

5. Amounts written off investments

			2025	2024
			£	£
			_______	_______

6. Dividends

Equity dividends

			2025	2024
			£	£

7. Intangible assets

	Goodwill	Total
	£	£
Cost
At 31 March 2024 and 30 March 2025	94,000	94,000
	_______	_______
Amortisation
At 31 March 2024 and 30 March 2025	94,000	94,000
	_______	_______
Carrying amount
At 30 March 2025	-	-
	_______	_______
At 30 March 2024	-	-
	_______	_______

8. Tangible assets

	Short leasehold property	Plant and machinery	Fixtures, fittings and equipment	Motor vehicles	Total
	£	£	£	£	£
Cost
At 31 March 2024	300,000	225,215	27,721	93,725	646,661
Additions	-	-	-	38,348	38,348
	_______	_______	_______	_______	_______
At 30 March 2025	300,000	225,215	27,721	132,073	685,009
	_______	_______	_______	_______	_______
Depreciation
At 31 March 2024	-	190,460	21,007	38,405	249,872
Charge for the year	-	8,689	1,678	21,874	32,241
	_______	_______	_______	_______	_______
At 30 March 2025	-	199,149	22,685	60,279	282,113
	_______	_______	_______	_______	_______
Carrying amount
At 30 March 2025	300,000	26,066	5,036	71,794	402,896
	_______	_______	_______	_______	_______
At 30 March 2024	300,000	34,755	6,714	55,320	396,789
	_______	_______	_______	_______	_______

Investment property

The investment properties were valued by Mr S Orrell, the Director, at their open market value.The historical cost of the investment properties was £237265.86 and the surplus arising upon revaluation has been transferred to the revaluation reserve.

9. Debtors

	2025	2024
	£	£
Trade debtors	19,787	28,387
Other debtors	4,201	26,368
	_______	_______
	23,988	54,755
	_______	_______

10. Creditors: amounts falling due within one year

	2025	2024
	£	£
Bank loans and overdrafts	36,843	61,275
Trade creditors	5,939	22,760
Corporation tax	259	33,746
Social security and other taxes	46,204	30,472
Other creditors	23,994	15,633
	_______	_______
	113,239	163,886
	_______	_______

11. Creditors: amounts falling due after more than one year

	2025	2024
	£	£
Bank loans and overdrafts	3,911	-
	_______	_______